Virchows Archiv

, Volume 448, Issue 4, pp 506–516

Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases

  • Frédéric Charlotte
  • Kamal Doghmi
  • Nathalie Cassoux
  • Hongtao Ye
  • Ming-Qing Du
  • Michèle Kujas
  • Annette Lesot
  • George Mansour
  • Phuc Lehoang
  • Nicole Vignot
  • Frédérique Capron
  • Véronique Leblond
Original Article

Abstract

To better characterize ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue (MZL-MALT), we analyzed the clinical and pathologic features of 23 patients (11 men, 12 women, median age 66 years). The tumor was confined to one ocular structure in 18 cases (conjunctiva, n=8; orbit, n=8; or lacrimal gland, n=2). Concurrent extraorbital disease was detected by the staging procedure in five patients, and preferentially involved other MALT sites. Histogenetic B cell marker studies, available in 13 cases, showed an early post-germinal center (GC) phenotype (BCL-6/IRF4+/CD138) (n=5) or a late post-GC phenotype (BCL-6/IRF4+/CD138+) (n=8), which could be helpful for discrimination from other types of small-B cell lymphoma. BCL10 was positive in 12 of 13 patients tested, with nuclear (n=4) or cytoplasmic (n=8) immunoreactivity. These staining patterns ruled out t(1;14)(p22;q32) translocation. T(11;18)(q21;q21), another MZL-MALT-specific translocation, was detected by reverse transcriptase polymerase chain reaction in four of 15 patients tested. Clinical outcome was excellent but the overall relapse rate was 26.1% with a median follow-up of 39 months (range 6–132 months). Regardless of the disease stage at diagnosis, combined chemotherapy and radiotherapy seemed to be more effective than chemotherapy alone in ocular adnexal MZL-MALT, as persistent complete remission was achieved in nine patients receiving combination therapy, while six of 14 patients treated with chemotherapy alone relapsed.

Keywords

MALT Lymphoma 

References

  1. 1.
    Adachi A, Tamaru JI, Kaneko K, Kuroda H, Miura I, Kojima T, Hoshino S, Ishinohasama R, Itoyama S (2004) No evidence of a correlation between BCL10 expression and API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma. Pathol Int 54:16–25CrossRefPubMedGoogle Scholar
  2. 2.
    Andriko JA, Swerdlow SH, Aguilera NI, Abbondanzo SL (2001) Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases. Am J Surg Pathol 25:742–751CrossRefPubMedGoogle Scholar
  3. 3.
    Auw-Haedrich C, Coupland SE, Kapp A, Schmitt-Graff A, Buchen R, Witschel H (2001) Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma. Br J Ophthalmol 85:63–69CrossRefPubMedGoogle Scholar
  4. 4.
    Baens M, Maes B, Steyls A, Geboes K, Marynen P, De Wolf-Peeters C (2000) The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 156:1433–1439PubMedGoogle Scholar
  5. 5.
    Baldini L, Blini M, Guffanti A, Fossati V, Colombi M, La Targia ML, Bertoni F, Alietti A, Neri A, Bertoni G (1998) Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Ann Oncol 9:779–781CrossRefPubMedGoogle Scholar
  6. 6.
    Barcus ME, Karageorge LS, Veloso YL, Kornstein MJ (2000) CD10 expression in follicular lymphoma versus reactive follicular hyperplasia: evaluation in paraffin-embedded tissues. Appl Immunohistochem Mol Morphol 8:263–266PubMedCrossRefGoogle Scholar
  7. 7.
    Cahill M, Barnes C, Moriarty P, Daly P, Kennedy S (1999) Ocular adnexal lymphoma-comparison of MALT lymphoma with other histological types. Br J Ophthalmol 83:742–747PubMedCrossRefGoogle Scholar
  8. 8.
    Carbone A, Gloghini A, Gaidano G, Franceschi S, Capello D, Drexler HG, Falini B, Dalla-Favera R (1998) Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin’s disease. Blood 92:2220–2228PubMedGoogle Scholar
  9. 9.
    Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the nomenclature committee on Hodgkin’s disease staging. Cancer 31:1860–1861Google Scholar
  10. 10.
    Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, Louie DC, Offit K, Chaganti RS, Dalla-Favera R (1995) BCL-6 protein is expressed in germinal center B cells. Blood 86:45–53PubMedGoogle Scholar
  11. 11.
    Cho EY, Han JJ, Ree HJ, Ko YH, Kang YK, Ahn HS, Ahn SD, Park CJ, Huh J (2003) Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol 73:87–96CrossRefPubMedGoogle Scholar
  12. 12.
    Coupland SE, Krause L, Delecluse HJ, Anagnostopoulos I, Foss HD, Hummel M, Bornfeld N, Lee WR, Stein H (1998) Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology 105:1430–1441CrossRefPubMedGoogle Scholar
  13. 13.
    Coupland SE, Hellmich M, Auw-Haedrich C, Lee WR, Anagnostopoulos I, Stein H (2005) Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases. Br J Ophthalmol 89:352–359CrossRefPubMedGoogle Scholar
  14. 14.
    Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, De Wolf-Peeters C, Hagemeijer A, Van den Berghe H, Marynen P (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93:3601–3609PubMedGoogle Scholar
  15. 15.
    Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, Dalakas M (2000) Waldenström’s macroglobulinemia: clinical features, complications and management. J Clin Oncol 18:214–226PubMedGoogle Scholar
  16. 16.
    Ellis JH, Banks PM, Campbell RJ, Liesegang TJ (1985) Lymphoid tumors of the ocular adnexa. Clinical correlation with the Working Formulation classification and immunoperoxidase staining of paraffin sections. Ophthalmology 92:1311–1324PubMedGoogle Scholar
  17. 17.
    Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, Gambacorta M, Pacini R, Alunni C, Natali-Tanci L, Ugolini B, Sebastiani C, Cattoretti G, Pileri S, Dalla-Favera R, Stein H (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells and activated T cells. Blood 95:2084–2092PubMedGoogle Scholar
  18. 18.
    Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29:252–260PubMedCrossRefGoogle Scholar
  19. 19.
    French Cooperative Group on CLL (1986) Effectiveness of CHOP regimen in advanced untreated chronic lymphocytic leukemia. Lancet 1:1346–1349Google Scholar
  20. 20.
    Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoma neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMedGoogle Scholar
  21. 21.
    Isaacson PG (1990) Lymphomas of the mucosa-associated tissue (MALT). Histopathology 16:617–619PubMedCrossRefGoogle Scholar
  22. 22.
    Jaffe ES, Harris NL, Stein H, Wardiman JW (ed) (2001). World Health Organization classification of tumors: pathology and genetics of tumors of hematopoietic and lymphoid tissues. International Agency for Research on Cancer Press, Lyon, FranceGoogle Scholar
  23. 23.
    Jakobiec FA, Iwamoto T, Patell M, Knowles DM (1986) Ocular adnexal monoclonal lymphoid tumors with a favorable prognosis. Ophthalmology 93:1547–1557PubMedGoogle Scholar
  24. 24.
    Kalla J, Stilgenbauer S, Schaffner C, Wolf S, Ott G, Greiner A, Rosenwald A, Dohner H, Muller-Hermelink HK, Lichter P (2000) Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma. Leukemia 14:1967–1974CrossRefPubMedGoogle Scholar
  25. 25.
    Knowles DM, Jakobiec FA, McNally L, Burke JS (1990) Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 21:959–973CrossRefPubMedGoogle Scholar
  26. 26.
    Lee JL, Kim MK, Lee KH, Hyun MS, Chung HS, Kim DS, Shin SO, Cho HS, Bae SH, Ryoo HM (2005) Extranodal marginal zone B cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexal. Ann Hematol 84:13–18CrossRefPubMedGoogle Scholar
  27. 27.
    Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, Isaacson PG, Du MQ (2001) T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 98:1182–1187CrossRefPubMedGoogle Scholar
  28. 28.
    Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wundisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson PG, Du MQ (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122:1286–1294CrossRefPubMedGoogle Scholar
  29. 29.
    Liu Z, Dong HY, Gordzya W, Tsang P, Cohen P, Stephenson CF, Berger CS, Wu CD, Weisberger J (2002) CD5- mantle cell lymphoma. Am J Clin Pathol 118:216–224CrossRefPubMedGoogle Scholar
  30. 30.
    Looi A, Gascoygne RD, Chhanabhai M, Connors JM, Rootman J, White VA (2005) Mantle cell lymphoma in the ocular adnexal region. Ophthalmology 112:114–119CrossRefPubMedGoogle Scholar
  31. 31.
    Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF, Yamaoka S, Seto M, Nunez G (2001) Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 276:19012–19019CrossRefPubMedGoogle Scholar
  32. 32.
    Mannami T, Yoshino T, Oshima K, Takase S, Kondo E, Ohara N, Nakagawa H, Ohtsuki H, Harada M, Akagi T (2001) Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of MALT lymphoma and reactive lymphoid hyperplasia. Mod Pathol 14:641–649CrossRefPubMedGoogle Scholar
  33. 33.
    McKelvie PA, McNab A, Francis IC, Fox R, O’Day J (2001) Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Experiment Ophthalmol 29:387–393PubMedCrossRefGoogle Scholar
  34. 34.
    Medeiros LJ, Harris NL (1989) Lymphoid infiltrates of the orbit and conjunctiva. A morphologic and immunophenotypic study of 99 cases. Am J Surg Pathol 13:459–471PubMedCrossRefGoogle Scholar
  35. 35.
    Motegi M, Yonezumi M, Suzuki H, Suzuki R, Hosokawa Y, Hosaka S, Kodera Y, Morishima Y, Nakamura S, Seto M (2000) API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 156:807–812PubMedGoogle Scholar
  36. 36.
    Nakamura T, Nakamura S, Yonezumi M, Suzuki T, Matsuura A, Yatabe Y, Yokoi T, Ohashi K, Seto M (2000) Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res 91:301–309PubMedGoogle Scholar
  37. 37.
    Nakata M, Matsuno Y, Katsumata N, Takenaka T, Kobayashi Y, Narabayashi M, Kagami Y, Ikeda H, Kaneko A, Tobinai K (1999) Histology according to the Revised European-American Lymphoma Classification significantly predicts the prognosis of ocular adnexal lymphoma. Leuk Lymphoma 32:533–543PubMedGoogle Scholar
  38. 38.
    Raderer M, Vorbeck F, Formanek M, Osterreicher C, Valencak J, Penz M, Kornek G, Hamilton G, Dragosics B, Chott A (2000) Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer 83:454–457PubMedCrossRefGoogle Scholar
  39. 39.
    Remstein ED, James CD, Kurtin PJ (2000) Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 156:1183–1188PubMedGoogle Scholar
  40. 40.
    Ruland J, Duncan GS, Elia A, del Barco Barrantes I, Nguyen L, Plyte S, Millar DG, Bouchard D, Wakeham A, Ohashi PS, Mak TW (2001) Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 104:33–42CrossRefPubMedGoogle Scholar
  41. 41.
    Takada S, Yoshino T, Tanikawi M, Nakamura N, Nakamine H, Oshima K, Sadahira Y, Inagaki H, Oshima K, Tadaastu A (2003) Involvement of the chromosomal translocation t(11–18) in some mucosa-associated lymphoid tissue lymphomas and diffuse large cell lymphomas of the ocular adnexa: evidence from multiplex reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization on using formalin fixed, paraffin-embeded specimens. Mod Pathol 16:445–452CrossRefPubMedGoogle Scholar
  42. 42.
    Uren AG, O’Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV, Dixit VM (2000) Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6:961–967PubMedGoogle Scholar
  43. 43.
    White WL, Ferry JA, Harris NL, Grove AS Jr (1995) Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 102:1994–2006PubMedGoogle Scholar
  44. 44.
    Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, Price H, Karran L, Majekodunmi O, Wlodarska I, Pan L, Crook T, Hamoudi R, Isaacson PG, Dyer MJ (1999) Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96:35–45CrossRefPubMedGoogle Scholar
  45. 45.
    Wohlschlaeger Ch, Lange K, Merz H, Feller AC (2003) Aberrant phenotype in mantle cell lymphoma. Leuk Lymphoma 44:269–273CrossRefPubMedGoogle Scholar
  46. 46.
    Wotherspoon AC, Diss TC, Pan LX, Schmid C, Kerr-Muir MG, Lea SH, Isaacson PG (1993) Primary low-grade B cell lymphoma of the conjunctiva: a mucosa-associated lymphoid tissue type lymphoma. Histopathology 23:417–424PubMedCrossRefGoogle Scholar
  47. 47.
    Ye H, Dogan A, Karran L, Willis TG, Chen L, Wlodarska I, Dyer MJ, Isaacson PG, Du MQ (2000) BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma. Am J Pathol 157:1147–1154PubMedGoogle Scholar
  48. 48.
    Ye H, Liu H, Attygalle A, Wotherspoon AC, Nicholson AG, Charlotte F, Leblond V, Speight P, Goodlad J, Lavergne-Slove A, Martin-Subero JI, Siebert R, Dogan A, Isaacson PG, Du MQ (2003) Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 102:1012–1018CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Frédéric Charlotte
    • 1
  • Kamal Doghmi
    • 3
  • Nathalie Cassoux
    • 2
  • Hongtao Ye
    • 4
  • Ming-Qing Du
    • 4
  • Michèle Kujas
    • 1
  • Annette Lesot
    • 1
  • George Mansour
    • 1
  • Phuc Lehoang
    • 2
  • Nicole Vignot
    • 1
  • Frédérique Capron
    • 1
  • Véronique Leblond
    • 3
  1. 1.Department of Pathology, Service d’Anatomie Pathologique (Pr F. Capron)Hôpital Pitié-SalpêtrièreParisFrance
  2. 2.Department of OphthalmologyPitié-Salpêtrière Hospital, AP-HPParisFrance
  3. 3.Department of HematologyPitié-Salpêtrière Hospital, AP-HPParisFrance
  4. 4.Department of HistopathologyUniversity College of LondonLondonUK

Personalised recommendations